Invesco’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.96M | Buy |
310,196
+18,260
| +6% | +$363K | ﹤0.01% | 2110 |
|
|
2025
Q4 | $4.82M | Buy |
291,936
+42,469
| +17% | +$717K | ﹤0.01% | 2257 |
|
|
2025
Q3 | $3.62M | Buy |
249,467
+29,672
| +13% | +$426K | ﹤0.01% | 2376 |
|
|
2025
Q2 | $3.07M | Buy |
219,795
+30,368
| +16% | +$427K | ﹤0.01% | 2407 |
|
|
2025
Q1 | $2.58M | Buy |
189,427
+67,949
| +56% | +$1.3M | ﹤0.01% | 2443 |
|
|
2024
Q4 | $2.48M | Sell |
121,478
-84,885
| -41% | -$2.17M | ﹤0.01% | 2534 |
|
|
2024
Q3 | $6.01M | Buy |
206,363
+90,131
| +78% | +$2.23M | ﹤0.01% | 2120 |
|
|
2024
Q2 | $2.7M | Buy |
116,232
+1,830
| +2% | +$35.1K | ﹤0.01% | 2469 |
|
|
2024
Q1 | $2.35M | Buy |
114,402
+35,263
| +45% | +$663K | ﹤0.01% | 2580 |
|
|
2023
Q4 | $1.7M | Sell |
79,139
-9,214
| -10% | -$182K | ﹤0.01% | 2678 |
|
|
2023
Q3 | $1.82M | Sell |
88,353
-4,568
| -5% | -$116K | ﹤0.01% | 2641 |
|
|
2023
Q2 | $2.74M | Buy |
92,921
+9,984
| +12% | +$281K | ﹤0.01% | 2529 |
|
|
2023
Q1 | $1.91M | Sell |
82,937
-5,802
| -7% | -$160K | ﹤0.01% | 2654 |
|
|
2022
Q4 | $2.47M | Buy |
88,739
+10,844
| +14% | +$323K | ﹤0.01% | 2561 |
|
|
2022
Q3 | $2.39M | Buy |
77,895
+4,229
| +6% | +$137K | ﹤0.01% | 2565 |
|
|
2022
Q2 | $2.17M | Buy |
73,666
+6,032
| +9% | +$158K | ﹤0.01% | 2674 |
|
|
2022
Q1 | $2.18M | Buy |
67,634
+23,170
| +52% | +$797K | ﹤0.01% | 2750 |
|
|
2021
Q4 | $1.98M | Sell |
44,464
-3,754
| -8% | -$178K | ﹤0.01% | 2798 |
|
|
2021
Q3 | $2.43M | Sell |
48,218
-335,347
| -87% | -$18.9M | ﹤0.01% | 2727 |
|
|
2021
Q2 | $30.1M | Buy |
383,565
+356,912
| +1,339% | +$22.1M | 0.01% | 1355 |
|
|
2021
Q1 | $1.52M | Sell |
26,653
-185,922
| -87% | -$12.4M | ﹤0.01% | 2885 |
|
|
2020
Q4 | $17.8M | Sell |
212,575
-101,824
| -32% | -$6.16M | 0.01% | 1494 |
|
|
2020
Q3 | $11.3M | Buy |
314,399
+24,784
| +9% | +$746K | ﹤0.01% | 1603 |
|
|
2020
Q2 | $7M | Sell |
289,615
-590
| -0.2% | -$13.9K | ﹤0.01% | 1820 |
|
|
2020
Q1 | $5.08M | Buy |
290,205
+99,697
| +52% | +$2.08M | ﹤0.01% | 1873 |
|
|
2019
Q4 | $3.32M | Sell |
190,508
-629
| -0.3% | -$10.5K | ﹤0.01% | 2400 |
|
|
2019
Q3 | $2.93M | Buy |
191,137
+71,540
| +60% | +$1.37M | ﹤0.01% | 2429 |
|
|
2019
Q2 | $2.48M | Sell |
119,597
-1,394
| -1% | -$31.2K | ﹤0.01% | 2591 |
|
|
2019
Q1 | $2.81M | Sell |
120,991
-44,845
| -27% | -$938K | ﹤0.01% | 2396 |
|
|
2018
Q4 | $3.43M | Buy |
165,836
+79,090
| +91% | +$1.43M | ﹤0.01% | 2184 |
|
|
2018
Q3 | $1.89M | Buy |
+86,746
| New | +$1.43M | ﹤0.01% | 2801 |
|
Other funds holding DNLI
VCM
VPM
